Background The duration of immunity in SARS-CoV-2 infected people remains unclear.
Neutralizing antibody responses are the best available correlate of protection against re …

The SARS-CoV-2 pandemic poses the greatest global public health challenge in a century.
Neutralizing antibody is a correlate of protection and data on kinetics of virus neutralizing …

Background Studies have found different waning rates of neutralising antibodies compared
with binding antibodies against SARS-CoV-2. The impact of neutralising antibody waning …

To understand the determinants of long-term immune responses to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the concurrent impact of vaccination and …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …

The protective effect of neutralizing antibodies in SARS-CoV-2 infected individuals is not yet
well defined. To address this issue, we have analyzed the kinetics of neutralizing antibody …

Background Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting
risk of reinfection and durability of vaccine protection. Methods This is a prospective …

Background Understanding mid-term kinetics of immunity to SARS-CoV-2 is the cornerstone
for public health control of the pandemic and vaccine development. However, current …

Major advances have been made in understanding the dynamics of humoral immunity
briefly after the acute coronavirus disease 2019 (COVID-19). However, knowledge …

To assess the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) antibodies produced by natural infection and describe the serological characteristics over …